Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1β

Digestive Diseases and Sciences

Volumn 52, Issue 1, 2007, Pages 93-102

  Wȩglarz, Ludmiła ^a   Wawszczyk, Joanna ^a   Orchel, Arkadiusz ^a   Jaworska Kik, Marzena ^a   Dzierzewicz, Zofia ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Bacterial lipopolysaccharide; Colonocytes; IL 1 ; IL 6; IL 8; Phytic acid

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PHYTIC ACID;

ARTICLE; BACTERIAL STRAIN; COLON MUCOSA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESULFOVIBRIO DESULFURICANS; HUMAN; HUMAN CELL; IMMUNOREGULATION; INTESTINE CELL; PRIORITY JOURNAL;

CACO-2 CELLS; CELLS, CULTURED; COLON; EPITHELIAL CELLS; HUMANS; IMMUNOASSAY; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; PHYTIC ACID;

EID: 33846378900     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9320-0     Document Type: Article

References (53)

1. Fujihashi K, Ernst PB (1999) A mucosal internet. Epithelial cell-immune cell interactions. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR (eds) Mucosal immunology. Academic Press, New York, pp 623-624
2. Jung HC, Eckmann L, Yang S, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95:55-65
3. Baggiolini M, Dewald B, Moser B (1994) Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97-179
4. Izutani R, Loh E, Reinecker HC, Ohno Y, Fusunyan RD, Lichtenstein GR, Rombeau JL, MacDermott RP (1995) Increased expression of interleukin-8 mRNA in ulcerative colitis and Crohn'disease mucosa and epithelial cells. Inflam Bowel Dis 1:37-47
5. Akira S, Hirano T, Taga T, Kishimito T (1999) Biology of multifunctional cytokines: IL-6 and related molecules (IL 1 and TNF). FASEB J 4:2860-2867
6. Wang Q, Wang JJ, Boyce S, Fischer JE, Hasselgren PO (1998) Endotoxemia and IL-1β stimulate mucosal IL-6 production in different parts of the gastrointestinal tract. J Surg Res 76:27-31
7. Zhang H, Niesel DW, Peterson JW, Klimpel GR (1998) Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect Immun 66:5196-5201
8. Caradonna L, Amati L, Magrone T, Pellegrino WM, Jirillo E, Caccavo D (2000) Enteric bacteria lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res 6:205-214
9. MacDermott RP (1999) Chemokines in the inflammatory bowel diseases. J Clin Immunol 19:266-272
10. Aoki KA (1978) Study of endotoxemia in ulcerative colitis and Crohn's disease. Acta Med Okoyama 32:147-158
11. Wȩglarz L, Dzierzewicz Z, Orchel A, Szczerba J, Jaworska-Kik M, Wilczok T (2003) Biological activity of Desulfovibrio desulfuricans lipopolysaccharides evaluated via interleukin-8 secretion by Caco-2 cells. Scand J Gastrenterol 38:73-79
12. Wȩglarz L, Dzierzewicz Z, Skop B, Orchel A, Parfiniewicz B, Wiśniowska B, Świa̧tkowska L, Wilczok T (2003) Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression. Cell Mol Biol Lett 8:991-1003
13. Dzierzewicz Z, Gawlik B, Cwalina B, Gonciarz K, Ziół kowski G, Gonciarz Z, Wilczok T (1994) Activity of sulphate-reducing bacteria in the human digestion tract. Bull Pol Acad Sci 42:171-176
14. Beerens H, Romond C (1977) Sulphate-reducing anaerobic bacteria in human feces. Am J Clin Nutr 30:1770-1776
15. Goldstein EJC, Citron DM, Peraino VA, Cross SA (2003) Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections. J Clin Microbiol 41:2752-2754
16. Tee W, Dyall-Smith M, Woods W, Eisen D (1996) Probable new species of Desulfovibrio isolated from a pyogenic liver abscess. J Clin Microbiol 34:1760-1764
17. Rafter JJ (2002) Scientific basis of biomarkers and benefits of functional foods for reduction of disease risk: cancer. Br J Nutr 88 (Suppl 2):S219-S224
18. Orzechowski A, Ostaszewski P, Jank M, Berwid SJ (2002) Bioactive substances of plant origin in food-impact on genomics. Reprod Nutr Dev 42:461-477
19. Owen RW, Weisgerber UM, Spiegelhalder B, Bartsch H (1996) Faecal phytic acid and its relation to other putative markers of risk for colorectal cancer. Gut 38:591-597
20. Minihane AM, Rimbach G (2002) Iron absorption and the iron binding and anti-oxidant properties of phytic acid. Int J Food Sci Tech 37:741-748
21. Shamsuddin AM, Vucenik I, Cole KE (1997) IP6: a novel anticancer agent. Life Sci 61:343-354
22. Ullah A, Shamsuddin AM (1990) Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 11:2219-2222
23. Jenab M, Thompson LU (1998) The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 19:1087-1092
24. Graf E, Eaton JW (1990) Antioxidant function of phytic acid. Free Radical Biol Med 8:61-69
25. Zhang Z, Song Y, Wang X-L (2005) Inositol hexaphosphate-induced enhancement of natural killer cell activity correlates with suppression of colon carcinogenesis in rats. World J Gastroenterol 11:5044-5046
26. 6) on the stimulated respiratory burst in human neutrophils. Biochim Biophys Acta 1094:309-316
27. Dzierzewicz Z, Cwalina B, Gawlik B, Wilczok T, Gonciarz Z (1997) Isolation and evaluation of susceptibility to sulphasalazine of Desulfovibrio desulfuricans strains from the human digestive tract. Acta Microbiol Pol 46:175-187
28. Postgate JR (1984) The sulphate-reducing bacteria. Cambridge University Press, Cambridge
29. Westphal O, Luderitz O, Bister FZ (1952) Bacterial strains and isolation of bacterial lipopolysaccharides. Naturforsch 78:148-154
30. Lawden KH, Pitts JM, Thomas JA, Lowe CR (1995) Rational computer-aided design of ligands that bind endotoxin. In: Levin J, Alving CR, Munford RS, Redl H (eds) Bacterial endotoxins: lipopolysaccharides from genes to therapy. Wiley-Liss, New York, pp 443-452
31. Schuerer-Maly C-C, Eckamnn L, Kagnoff MF, Falco MT, Maly F-E (1994) Colonic epithelial cell lines as a source of interleukin-8 stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 81:85-91
32. Fusunyan RD, Quinn JJ, Ohno Y, MacDermott RP, Sanderson IA (1998) Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide. Pediatr Res 43:84-90
33. Erickson KL (1986) Dietary fat modulation of immune response. Int J Immunopharmacol 8:529-543
34. Yoshida H, Miura S, Kishikawa H, Hirokawa M, Nakamizo H, Nakatsumi RC, Suzuki H, Saito H, Ishii H (2001) Fatty acids enhance GRO/CINC-1 and interleukin-6 production in rat intestinal epithelial cells. J Nutr 131:2943-2950
35. Kjaer TMR, Frokier H (2002) Modulation of ovomucoid-specific oral tolerance in mice fed plant extracts containing lectins. Br J Nutr 88:671-680
36. Lavelle EC, Grant G, Pusztai A, Pfuller U, O'Hagan DT (2001) The identification of plant lectins with mucosal adjuwant activity. Immunology 102:77-86
37. Haas H, Falcone FH, Schramm G, Haisch K, Gibbs BF, Klaucke J, Poppelmann M, Becker WM, Gabius HJ, Schlaak M (1999) Dietary lectins can induce in vitro release of IL-4 and IL-13 from human basophils. Eur J Immunol 29:918-927
38. Sandstrom B (2001) Micronutrient interactions: effect on absorption and bioavailability. Br J Nutr 85:S181-S185
39. Thurnham DI (2004) An overview of interactions between micronutrients and of micronutrients with drugs, genes and immune mechanisms. Nutr Res Rev 17:211-240
40. Wellinghausen N, Kirchner H, Rink L (1997) The immunobiology of zinc. Immunol Today 16:519-521
41. Rink L, Gabriel P (2000) Zinc and the immune system. Proc Nutr Soc 59:541-552
42. Cui L, Takagi Y, Wasa M, Liboshi Y, Khan J, Nezu R, Okada A (1997) Induction of nitric oxide synthase in rat intestine by interleukin-1α may explain diarrhea associated with zinc deficiency. J Nutr 127:1729-1736
43. Cui L, Takagi Y, Wasa M, Sando K, Khan J, Okada A (1999) Nitric oxide synthase inhibitor attenuates intestinal damage induced by zinc deficiency in rats. J Nutr 129:792-798
44. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D (1990) Role of interleukin-1 in inflammatory bowel disease-enhanced production during active disease. Gut 31:686-689
45. Wang L, Walia B, Evans J, Gewirtz A, Merli D, Sitaraman SV (2003) IL-6 induces NF-κB activation in the intestinal epithelia. J Immunol 171:3194-3201
46. McGee DW, Beagley KW, Aicher WK, McGhee JR (1993) Transforming growth factor-β and IL-1β act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol 2:970-978
47. Hershko DD, Robb BW, Luo G, Hasselgren P-O (2002) Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am J Physiol Regul Integr Comp Physiol 283:R1140-R1148
48. Wang Q, Sun X, Pritts TA, Wong HR, Hasselgren PO (2000) Induction of the stress response increases IL-6 production in intestinal mucosa of endotoxemic mice. Clin Sci 99:489-496
49. McGee DW, Beagley KW, Aicher WK, McGhee RM (1992) Transforming growth factor-β enhances interleukin-6 secretion by intestinal epithelial cells. Immunology 77:7-12
50. Pritts TA, Hungness ES, Hershko DD, Robb BW, Sun X, Luo GJ, Fischer JE, Wong HR, Hasselgren PO (2002) Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells. Am J Physiol Regul Integr Cop Physiol 282:R1016-R1026
51. Wilson M, Seymour R, Henderson B (1998) Bacterial perturbation of cytokine networks. Infect Immun 66:2401-2409
52. Eggleton P (1999) Effect of IP6 on human neutrophil cytokine production and cell morphology. Anticancer Res 19:3711-3716.
53. Cecconi O, Nelson RM, Roberts WG, Hanasaki K, Mannori G, Schultz C, Ulich TR, Aruffo A, Bevilaqua MP (1994) Inositol polyanions. Noncarbohydrate inhibitors of L- and P-selectin that block inflammation. J Biol Chem 269:15060-15066